Desvenlafaxine

Routes
Oral (PO)
Half-Life (t½)
PO: 11h
Formula
C16H25NO2
Molecular Weight
263.38 g/mol
PubChem CID
125017
Aliases
Pristiq

Pharmacological Mechanism

SNRI — active O-desmethyl metabolite of venlafaxine. Bypasses CYP2D6 conversion → more consistent levels in CYP2D6 poor metabolizers. Stronger NE component at therapeutic doses than venlafaxine.

Half-Life & Elimination Curve (PO: 11h)

100%50%25%12.5%0%0h0×t½11h1×t½22h2×t½33h3×t½44h4×t½55h5×t½0×t½ (0h): 100% remaining (~0.101 mg/L)1×t½ (11h): 50% remaining (~50.3 µg/L)2×t½ (22h): 25% remaining (~25.1 µg/L)3×t½ (33h): 12.5% remaining (~12.6 µg/L)4×t½ (44h): 6.3% remaining (~6.29 µg/L)5×t½ (55h): 3.1% remaining (~3.14 µg/L)
Plasma (PO)t½ Decay (11h)
  • 0×t½0h100% (0.101 mg/L)
  • 1×t½11h50% (50.3 µg/L)
  • 2×t½22h25% (25.1 µg/L)
  • 3×t½33h12.5% (12.6 µg/L)
  • 4×t½44h6.3% (6.29 µg/L)
  • 5×t½55h3.1% (3.14 µg/L)
Elimination t½11h (PO)
Rate Constant (ke)0.063 h⁻¹
Time to Peak (Tmax)7.37h
Est. Peak (Cmax)0.101 mg/L
Clearance (CL)15.8 L/h
97% Washout (5×t½)55h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References